日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tucatinib-trastuzumab-capecitabine for treatment of leptomeningeal metastasis in women with HER2(+) breast cancer: TBCRC049 phase 2 study results

Tucatinib-trastuzumab-capecitabine治疗HER2(+)乳腺癌女性软脑膜转移:TBCRC049 II期研究结果

Murthy, Rashmi K; O'Brien, Barbara J; Berry, Donald A; Singareeka-Raghavendra, Akshara; Monroe, Maria Gule; Johnson, Jason; White, Jason; Schwartz-Gomez, Jill; Topletz-Erickson, Ariel; Lobbous, Mina; Riley, Kristen; Melisko, Michelle; Morikawa, Aki; Ferguson, Sherise D; de Groot, John F; Krop, Ian E; Valero, Vicente; Rimawi, Mothaffar F; Wolff, Antonio C; Tripathy, Debu; Lin, Nancy U; Stringer-Reasor, Erica M

Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)

视觉和计算机评估的肿瘤浸润淋巴细胞在早期三阴性乳腺癌中的预后价值(TBCRC-030)

Nader-Marta, Guilherme; Chu, Xiangying; Mukhopadhyay, Satabhisa; Abramson, Vandana G; Brufsky, Adam; Stringer-Reasor, Erica Michelle; Dent, Susan Faye; Traina, Tiffany A; Carey, Lisa A; Rimawi, Mothaffar F; Specht, Jennifer M; Miller, Kathy D; Santa-Maria, Cesar Augusto; Dasgupta, Tathagata; Kurt, Busem Binboğa; DeMeo, Michelle; Krop, Ian E; Tung, Nadine M; Schnitt, Stuart J; Tayob, Nabihah; Mayer, Erica L

Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA

从无细胞DNA中检测酪氨酸激酶抑制剂的异质性耐药机制

Parsons, Heather A; Messer, Conor; Santos, Katheryn; Weiss, Jakob; Merrell, David; Danysh, Brian P; Hughes, Melissa E; Kirkner, Gregory J; Patel, Ashka; Hess, Julian; Sendrick, Kerry; Stewart, Chip; Grant, Elizabeth; Schlueter-Kuck, Kristy; Grinshpun, Albert; Wagle, Nikhil; Veeraraghavan, Jamunarani; Leone, Jose Pablo; Freedman, Rachel A; Metzger, Otto; Schiff, Rachel; Winer, Eric P; Tolaney, Sara M; Rimawi, Mothaffar; Krop, Ian E; Getz, Gad; Lin, Nancy U

A composite (18)F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026)

一种基于 (18)F-FDG PET/CT 和 HER2 组织的复合生物标志物,用于预测 HER2 阳性乳腺癌对新辅助帕妥珠单抗和曲妥珠单抗的反应 (TBCRC026)

Hennessy, Maeve A; Cimino-Mathews, Ashley; Carter, Jodi M; Kachergus, Jennifer M; Ma, Yaohua; Leal, Jeffrey P; Solnes, Lilja B; Abramson, Vandana G; Carey, Lisa A; Rimawi, Mothaffar; Specht, Jennifer; Storniolo, Anna Maria; Vaklavas, Christos; Krop, Ian; Winer, Eric; Denbow, Rita; Valero, Vincente; Wolff, Antonio C; Wahl, Richard L; Huang, Chiung-Yu; Stearns, Vered; Thompson, E Aubrey; Connolly, Roisin M

Real-World Evidence Acceptability and Use in Breast Cancer Treatment Decision-Making in the United States: Call-to-Action from a Multidisciplinary Think Tank

美国乳腺癌治疗决策中真实世界证据的可接受性和应用:来自多学科智库的行动呼吁

Khozin, Sean; Dreyer, Nancy A; Galante, Dominic; Liu, Raymond; Neumann, Peter; Nussbaum, Nathan; O'Shaughnessy, Joyce; Patt, Debra; Rimawi, Mothaffar; Rugo, Hope; Tolaney, Sara M; Weiss, Marisa; Brufsky, Adam

Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

源自患者的三阴性乳腺癌异种移植模型能够对化疗反应进行解卷积和预测

Lei Jonathan T, Dobrolecki Lacey E, Huang Chen, Srinivasan Ramakrishnan R, Vasaikar Suhas V, Lewis Alaina N, Sallas Christina, Zhao Na, Cao Jin, Landua John D, Moon Chang In, Liao Yuxing, Hilsenbeck Susan G, Osborne C Kent, Rimawi Mothaffar F, Ellis Matthew J, Petrosyan Varduhi, Wen Bo, Li Kai, Saltzman Alexander B, Jain Antrix, Malovannaya Anna, Wulf Gerburg M, Marangoni Elisabetta, Li Shunqiang, Kraushaar Daniel C, Wang Tao, Damodaran Senthil, Zheng Xiaofeng, Meric-Bernstam Funda, Echeverria Gloria V, Anurag Meenakshi, Chen Xi, Welm Bryan E, Welm Alana L, Zhang Bing, Lewis Michael T

Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT

辅助曲妥珠单抗-美坦新与紫杉醇联合曲妥珠单抗治疗I期人表皮生长因子受体2阳性乳腺癌:ATEMPT研究的5年结果及相关性分析

Tarantino, Paolo; Tayob, Nabihah; Villacampa, Guillermo; Dang, Chau; Yardley, Denise A; Isakoff, Steven J; Valero, Vicente; Faggen, Meredith; Mulvey, Therese; Bose, Ron; Weckstein, Douglas; Wolff, Antonio C; Reeder-Hayes, Katherine; Rugo, Hope S; Ramaswamy, Bhuvaneswari; Zuckerman, Dan; Hart, Lowell; Gadi, Vijayakrishna K; Constantine, Michael; Cheng, Kit; Garrett, Audrey Merrill; Marcom, P Kelly; Albain, Kathy; DeFusco, Patricia; Tung, Nadine; Ardman, Blair; Nanda, Rita; Jankowitz, Rachel C; Rimawi, Mothaffar; Abramson, Vandana; Pohlmann, Paula R; Van Poznak, Catherine; Forero-Torres, Andres; Liu, Minetta C; Ruddy, Kathryn J; Waks, Adrienne G; DeMeo, Michelle; Burstein, Harold J; Partridge, Ann H; Dell'Orto, Patrizia; Russo, Leila; Krause, Emma; Newhouse, Daniel J; Kurt, Busem Binboğa; Mittendorf, Elizabeth A; Schneider, Bryan; Prat, Aleix; Winer, Eric P; Krop, Ian E; Tolaney, Sara M

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial

接受新辅助阿那曲唑、氟维司群或二者联合治疗的雌激素受体丰富/ERBB2阴性绝经后乳腺癌患者的内分泌敏感性疾病发生率:一项3期随机临床试验

Ma, Cynthia X; Suman, Vera J; Sanati, Souzan; Vij, Kiran; Anurag, Meenakshi; Leitch, A Marilyn; Unzeitig, Gary W; Hoog, Jeremy; Fernandez-Martinez, Aranzazu; Fan, Cheng; Gibbs, Richard A; Watson, Mark A; Dockter, Travis J; Hahn, Olwen; Guenther, Joseph M; Caudle, Abigail; Crouch, Erika; Tiersten, Amy; Mita, Monica; Razaq, Wajeeha; Hieken, Tina J; Wang, Yang; Rimawi, Mothaffar F; Weiss, Anna; Winer, Eric P; Hunt, Kelly K; Perou, Charles M; Ellis, Matthew J; Partridge, Ann H; Carey, Lisa A

Calibrating Observational Health Record Data Against a Randomized Trial

利用随机试验校准观察性健康记录数据

Merola, David; Campbell, Ulka; Lenis, David; Schneeweiss, Sebastian; Wang, Shirley; Madsen, Ann; Carrigan, Gillis; Chia, Victoria; Ovbiosa, Osayi E; Pinheiro, Simone; Pace, Nelson; Bruno, Amanda; Stewart, Mark; Khosla, Sajan; Zhang, Yiduo; Rimawi, Mothaffar; Hendricks-Sturrup, Rachele; Huang, Jenny; Taylor, Aliki; Jiao, XiaoLong; Becnel, Lauren; McRoy, Lynn; Eckert, Joy; Rodriguez, Carla; Lunacsek, Orsolya; Harvey, Raymond; Greshock, Joel; Sarsour, Khaled; Belli, Andrew; Wang, C K; Fernandes, Laura; Chen, James; San Francisco, Brian; Sangli, Chithra; Natanzon, Yana; Chan, K Arnold; Dhopeshwarkar, Neil; Shapiro, Mark; Wasserman, Asher; Quinn, Jameson; Rees, Megan; Robinson, Travis; Taylor, Ben; Rider, Jennifer R

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

来自 AURORA 美国网络的对原发性和转移性乳腺肿瘤的多组学分析发现了转移的微环境和表观遗传驱动因素

Garcia-Recio, Susana; Hinoue, Toshinori; Wheeler, Gregory L; Kelly, Benjamin J; Garrido-Castro, Ana C; Pascual, Tomas; De Cubas, Aguirre A; Xia, Youli; Felsheim, Brooke M; McClure, Marni B; Rajkovic, Andrei; Karaesmen, Ezgi; Smith, Markia A; Fan, Cheng; Ericsson, Paula I Gonzalez; Sanders, Melinda E; Creighton, Chad J; Bowen, Jay; Leraas, Kristen; Burns, Robyn T; Coppens, Sara; Wheless, Amy; Rezk, Salma; Garrett, Amy L; Parker, Joel S; Foy, Kelly K; Shen, Hui; Park, Ben H; Krop, Ian; Anders, Carey; Gastier-Foster, Julie; Rimawi, Mothaffar F; Nanda, Rita; Lin, Nancy U; Isaacs, Claudine; Marcom, P Kelly; Storniolo, Anna Maria; Couch, Fergus J; Chandran, Uma; Davis, Michael; Silverstein, Jonathan; Ropelewski, Alexander; Liu, Minetta C; Hilsenbeck, Susan G; Norton, Larry; Richardson, Andrea L; Symmans, W Fraser; Wolff, Antonio C; Davidson, Nancy E; Carey, Lisa A; Lee, Adrian V; Balko, Justin M; Hoadley, Katherine A; Laird, Peter W; Mardis, Elaine R; King, Tari A; Perou, Charles M